CD34(+) progenitors are reproducibly recovered in thawed umbilical grafts, and positively influence haematopoietic reconstitution after transplantation

Bone Marrow Transplantation
C LemarieG Michel

Abstract

Cord blood (CB) units are increasingly used for allogeneic transplantation. Cell dose, a major factor for CB selection, is evaluated before freezing by each CB bank, using various techniques. This may introduce variability and affect the prediction of cell recovery after thawing, or haematopoietic reconstitution. Forty-two children were transplanted at the same institution with unrelated CB units. All units were thawed and evaluated at the same cell therapy facility, using standard procedures. We investigated: (i) factors that affect cell loss after thawing, and (ii) the importance of CD34(+) cell doses. Prefreeze and post-thaw CD34(+) cell doses were statistically correlated, thus suggesting that variability in numeration techniques used by different CB banks does not compromise the biological and clinical value of these figures. CD34(+) cell recovery appeared to be correlated with the absolute number of CD34(+) cells per frozen bag. Infused CD34(+) is the cell dose that better correlates with platelet reconstitution delay; in addition, when using a quartile comparison, haematopoietic recovery appeared to be related with prefreeze and post-thaw CD34(+) cell doses. We conclude that enumeration of CD34(+) cells in CB units is of...Continue Reading

References

Oct 24, 1995·Proceedings of the National Academy of Sciences of the United States of America·P RubinsteinC E Stevens
Sep 1, 1993·The Journal of Experimental Medicine·P M LansdorpH Mayani
Dec 28, 1994·Journal of Immunological Methods·J K NicholsonL Bryan
Mar 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·G RisdonH E Broxmeyer
Mar 4, 1993·The New England Journal of Medicine·N A KernanJ McCullough
Jul 18, 1996·The New England Journal of Medicine·J KurtzbergP Rubinstein
May 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R SzydloM M Horowitz
Nov 26, 1998·The New England Journal of Medicine·P RubinsteinC E Stevens
Apr 1, 1999·Bone Marrow Transplantation·S ArmitageM Contreras
Jun 5, 2002·Cytotherapy·M I GodinhoI L Barbosa
Mar 31, 2004·Experimental Hematology·Eliane GluckmanUNKNOWN Eurocord Group
Apr 17, 2004·British Journal of Haematology·Sue DaveyCristina V Navarrete
Nov 27, 2004·The New England Journal of Medicine·Mary J LaughlinMary M Horowitz
Nov 27, 2004·The New England Journal of Medicine·Vanderson RochaUNKNOWN Eurocord-Netcord Registry
Apr 6, 2006·Transfusion·Gary MoroffUNKNOWN Biomedical Excellence for Safer Transfusion (BEST) Collaborative
Apr 6, 2006·Transfusion·Liliana Rivadeneyra-EspínozaAlejandro Ruiz-Argüelles

❮ Previous
Next ❯

Citations

Aug 6, 2010·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Francesco ZinnoGiancarlo Isacchi
Aug 3, 2010·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·B PanterneM Rosenzwajg
Feb 1, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Kristin M PageJoanne Kurtzberg
Jul 6, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Vincent BarlogisGerard Michel
Aug 1, 2020·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Ioannis PolitikosUNKNOWN American Society for Transplantation and Cellular Therapy Cord Blood Special Interest Group
Sep 22, 2021·Annals of Hematology·Nobuhiro HiramotoUNKNOWN Adult Aplastic Anemia Working Group of the Japanese Society for Hematopoietic Cell Transplantation

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.